DrugPatentWatch Database Preview
Litigation Details for Novartis Pharmaceuticals Corporation v. Apotex Inc. (D. Del. 2020)
» See Plans and Pricing
Novartis Pharmaceuticals Corporation v. Apotex Inc. (D. Del. 2020)
| Docket | Start Trial | Date Filed | 2020-01-27 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:1 Patent Infringement | Assigned To | |
| Jury Demand | None | Referred To | |
| Patents | 10,543,179; 9,187,405 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Apotex Inc.
The small molecule drug covered by the patents cited in this case is Start Trial .
Details for Novartis Pharmaceuticals Corporation v. Apotex Inc. (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-01-27 | 1 | Complaint | mg, prior to expiration of U.S. Patent No. 10,543,179 (“the ’179 patent”). ME1 32500579v.1 Case 1…. This is an action for patent infringement arising under the patent laws of the United States, …prior to the expiration of U.S. Patent No. 9,187,405 (“the ’405 patent”). 9. In …)(IV), with respect to the ’405 patent asserting that the ’405 patent is invalid, unenforceable, and/…20 Page 7 of 40 PageID #: 7 patent asserting that the ’405 patent is invalid, unenforceable, and/or | External link to document |
| 0000-00-00 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,543,179. (kmd) (Entered: 01… 28 January 2020 1:20-cv-00133 835 Patent - Abbreviated New Drug Application(ANDA) | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
